Study the mRNA level of IL-27/IL-27R pathway molecules in kidney transplant rejection
https://doi.org/10.4081/aiua.2023.11691
Accepted: October 7, 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background: Renal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant rejection represents a vital, life-preserving endeavor posttransplantation. In this context, the impact of cytokines, notably IL-27, assumes a critical role in managing immune responses aimed at countering rejection. Consequently, this investigation endeavors to explore the precise function of IL-27 and its associated cytokines in the context of kidney transplant rejection. Methods: The study involved the acquisition of blood samples from a cohort of participants, consisting of 61 individuals who had undergone kidney transplantation (comprising 32 nonrejected patients and 29 rejected patients), and 33 healthy controls. The expression levels of specific genes were examined using SYBR Green Real-time PCR. Additionally, the evaluation encompassed the estimation of the ROC curve, the assessment of the relationship between certain blood factors, and the construction of protein-protein interaction networks for the genes under investigation. Results: Significant statistical differences in gene expression levels were observed between the rejected group and healthy controls, encompassing all the genes examined, except for TLR3 and TLR4 genes. Moreover, the analysis of the Area Under the Curve (AUC) revealed that IL-27, IL-27R, TNF-α, and TLR4 exhibited greater significance in discriminating between the two patient groups. These findings highlight the potential importance of IL-27, IL-27R, TNF-α, and TLR4 as key factors for distinguishing between individuals in the rejected group and those in the healthy control group. Conclusions: In the context of kidney rejections occurring within the specific timeframe of 2 weeks to 2 months post-transplantation, it is crucial to emphasize the significance of cytokines mRNA level, including IL-27, IL-27R, TNF-α, and TLR4, in elucidating and discerning the diverse immune system responses. The comprehensive examination of these cytokines’ mRNA level assumes considerable importance in understanding the intricate mechanisms underlying kidney rejection processes during this critical period.
Kälble T, Lucan M, Nicita G, et al. Eau guidelines on renal transplantation. Eur Urol. 2005; 47:156-66. DOI: https://doi.org/10.1016/j.eururo.2004.02.009
Traitanon O, Poggio ED, Fairchild RL, et al. Molecular monitoring of alloimmune-mediated injury in kidney transplant patients. Curr Opin Nephrol Hypertens. 2014; 23:625-30. DOI: https://doi.org/10.1097/MNH.0000000000000064
Joosten SA, Sijpkens YWJ, Van Kooten C, Paul LC. Chronic renal allograft rejection: Pathophysiologic considerations. Kidney Int. 2005; 68:1-13. DOI: https://doi.org/10.1111/j.1523-1755.2005.00376.x
Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric
cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+T cells. Immunity. 2002; 16:779-90. DOI: https://doi.org/10.1016/S1074-7613(02)00324-2
Sprecher CA, Grant FJ, Baumgartner JW, et al. Cloning and characterization of a novel class I cytokine receptor. Biochem Biophys Res Commun. 1998; 246:82-90. DOI: https://doi.org/10.1006/bbrc.1998.8576
Le Texier L, Thebault P, Carvalho-Gaspar M, et al.
Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation. Transplantation. 2012; 94:226-33. DOI: https://doi.org/10.1097/TP.0b013e31825b0c38
Afshari A, Yaghobi R, Azarpira N, et al. Evaluation of Interleukin- 21, 23 and 27 mRNA expression and protein level in liver transplant patients. Iran J Allergy Asthma Immunol. 2018; 17:298-307. DOI: https://doi.org/10.18502/ijaai.v17i4.89
Ayasoufi K, Zwick DB, Fan R, et al. Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation. JCI Insight. 2019; 4:e125489 DOI: https://doi.org/10.1172/jci.insight.125489
Pontrelli P, Rascio F, Zaza G, et al. Interleukin-27 is a potential marker for the onset of post-transplant malignancies. Nephrology Dialysis Transplantation. 2019; 34:157-66. DOI: https://doi.org/10.1093/ndt/gfy206
Haas M, Loupy A, Lefaucheur C, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cellmediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. American Journal of Transplantation. 2018; 18:293-307. DOI: https://doi.org/10.1111/ajt.14625
Rahimi Z, Yaghobi R, Afshari A, et al. The effect of BKV reactivation on cytokines behavior in kidney transplanted patients. BMC Nephrol. 2022; 23:20. DOI: https://doi.org/10.1186/s12882-021-02645-y
Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation. 1993; 55:752-7. DOI: https://doi.org/10.1097/00007890-199304000-00013
Kamoun M. Cellular and molecular parameters in human renal allograft rejection. In: Clinical Biochemistry. Clin Biochem. 2001; 34:29-34. DOI: https://doi.org/10.1016/S0009-9120(00)00188-0
Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation. 1994; 57:857-9. DOI: https://doi.org/10.1097/00007890-199403270-00015
Ramanathan V, Goral S, Helderman JH. Renal transplantation. Semin Nephrol. 2001; 21:213-9. DOI: https://doi.org/10.1053/snep.2001.21213
Goldfarb-Rumyantzev AS, Naiman N. Genetic predictors of acute renal transplant rejection. Nephrol Dial Transplant. 2010; 25:1039-47. DOI: https://doi.org/10.1093/ndt/gfp782
Nickerson P. Post-transplant monitoring of renal allografts: are we there yet? Curr Opin Immunol 2009; 21. 563-8. DOI: https://doi.org/10.1016/j.coi.2009.07.014
Wirtz S, Becker C, Fantini MC, et al. EBV-Induced Gene 3
Transcription Is Induced by TLR Signaling in Primary Dendritic Cells via NF-κB Activation. J Immunol. 2005; 174:2814-24 DOI: https://doi.org/10.4049/jimmunol.174.5.2814
Yoshida H, Miyazaki Y, Wang S, Hamano S. Regulation of
defense responses against protozoan infection by interleukin-27 and related cytokines. J Biomed Biotechnol. 2007; 2007:79401 DOI: https://doi.org/10.1155/2007/79401
Villarino AV, Larkin J, Saris CJM, et al. Positive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation. J Immunol 2005; 174:7684-91. DOI: https://doi.org/10.4049/jimmunol.174.12.7684
Batten M, Ghilardi N. The biology and therapeutic potential of interleukin 27. J Mol Med. 2007; 85:661-72. DOI: https://doi.org/10.1007/s00109-007-0164-7
Neufert C, Becker C, Wirtz S, et al. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol. 2007; 37:1809-16. DOI: https://doi.org/10.1002/eji.200636896
Afshari A, Yaghobi R, Karimi MH, et al. Interleukin-17 gene expression and serum levels in acute rejected and non-rejected liver transplant patients. Iran J Immunol. 2014; 11:29-39.
Liu J, Guan X, Ma X. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-γ-mediated pathways. J Exp Med. 2007; 204:141-52. DOI: https://doi.org/10.1084/jem.20061440
Zhang J, Zhang H, Wang Z, et al. BTLA suppress acute rejection via regulating TCR downstream signals and cytokines production in kidney transplantation and prolonged allografts survival. Sci Rep. 2019; 9:1-14. DOI: https://doi.org/10.1038/s41598-019-48520-7
Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally
Significant Renal Allograft Rejection Is Defined by Transcriptional Criteria. Am J Transplant. 2005; 5:573-81. DOI: https://doi.org/10.1111/j.1600-6143.2005.00719.x
Renesto PG, Ponciano VC, Cenedeze MA, et al. High Expression of Tim-3 mRNA in Urinary Cells from Kidney Transplant Recipients with Acute Rejection. Am J Transplant. 2007; 7:1661-5. DOI: https://doi.org/10.1111/j.1600-6143.2007.01795.x
Bennett C, Waters A, Moran J, et al. Predominant Inflammatory and Th1 biased cytokine secretion pre- and post- kidney transplantation. Eastern Journal of Medicine. 2011; 16:22-5.
Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 1995; 5: 392-9. DOI: https://doi.org/10.1016/S0962-8924(00)89088-1
Al-Lamki RS, Wang J, Skepper JN, et al. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest. 2001; 81:1503-15. DOI: https://doi.org/10.1038/labinvest.3780364
Hummel M, Kurian SM, Lin S, et al. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model. Transplantation. 2009; 87:178-88. DOI: https://doi.org/10.1097/TP.0b013e3181938971
Al-Lamki RS, Mayadas TN. TNF receptors: Signaling pathways and contribution to renal dysfunction. Kidney Int 2015; 87:281-96. DOI: https://doi.org/10.1038/ki.2014.285
Ciftci HS, Demir E, Karadeniz MS, et al. Serum and urinary levels of tumor necrosis factor-alpha in renal transplant patients. Exp Clin Transplant. 2018; 16:671-675.
Budak D, Yilmaz VT, Akbas H, et al. Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation. Ren Fail. 2015; 37:871-6. DOI: https://doi.org/10.3109/0886022X.2015.1015425
Krams SM, Wang M, Castillo RO, et al. Toll-like receptor 4 contributes to small intestine allograft rejection. Transplantation. 2010 Dec 27; 90:1272-7. DOI: https://doi.org/10.1097/TP.0b013e3181fdda0d
Goldberg A, Parolini M, Chin BY, et al. Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J 2007; 21:2840-8. DOI: https://doi.org/10.1096/fj.06-7910com
Keshavarz Z, Zareei N, Afshari A, et al. TLR2 and TLR4 mRNA expression levels in liver transplant patients with acute rejection. Immunobiology. 2021; 226:152107. DOI: https://doi.org/10.1016/j.imbio.2021.152107
Heidari M, Ebadi P, Abbasi S, et al. Gene expression of toll-like receptors 2 and 4 in renal transplant rejection. Exp Clin Transplant. 2020; 18:757-62. DOI: https://doi.org/10.6002/ect.2019.0242
Testro AG, Visvanathan K, Skinner N, et al. Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4. J Gastroenterol Hepatol. 2011; 26:155-63. DOI: https://doi.org/10.1111/j.1440-1746.2010.06324.x
Nogueira E, Ponciano VC, Naka ÉL, et al. Toll-like receptors-related genes in kidney transplant patients with chronic allograft nephropathy and acute rejection. Int Immunopharmacol. 2009; 9:673-6. DOI: https://doi.org/10.1016/j.intimp.2008.11.018
Assadiasl S, Mousavi MJ, Amirzargar A. Toll-like receptor 4 in renal transplant. Exp Clin Transplant 2018; 16:245-52.
Dessing MC, Bemelman FJ, Claessen N, et al. Intragraft Toll-like receptor profiling in acute renal allograft rejection. Nephrol Dial Transplant. 2010; 25:4087-92. DOI: https://doi.org/10.1093/ndt/gfq589
Krüger B, Banas MC, Walberer A, et al. A comprehensive genotype- phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci. 2010; 119:535-44. DOI: https://doi.org/10.1042/CS20100190
Chattopadhyay S, Veleeparambil M, Poddar D, et al. EGFR kinase activity is required for TLR4 signaling and the septic shock response. EMBO Rep. 2015; 16:1535-47. DOI: https://doi.org/10.15252/embr.201540337
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
